Tobacco smoking is the first cause of preventable death in modern countries. Nicotine replacement therapy or sustained release bupropion helps smoking cessation, but relapse rates are still very high. Nicotine, like other drugs of abuse, activates the dopamine mesolimbic system, which originates in the ventral tegmental area and projects notably to the nucleus accumbens. Situations or environmental stimuli previously associated with cigarette smoking, for example, smell of cigarette smoke, can elicit craving in abstinent smokers and promote relapse. Reducing the effects of nicotineassociated cues might therefore have potential therapeutic utility for smoking cessation. Such an approach has been validated for cocaine in animals, by using the dopamine D 3 receptor-selective partial agonist BP 897, which inhibits cocaine cue-induced drug-seeking behavior. Here we show that rats repeatedly injected with nicotine in a particular environment develop nicotineconditioned locomotor responses, accompanied by an increase in D 3 receptor expression in the nucleus accumbens. This conditioned behavior was inhibited by BP 897 or a selective D 3 receptor antagonist, suggesting that antagonizing dopamine selectively at the D 3 receptor disrupts nicotine-conditioned effects and might represent a novel therapeutic approach for smoking cessation.
In animals, drug-associated environmental stimuli, initially neutral, progressively acquire reinforcing properties able to maintain conditioned responses and reinstate these responses after extinction. 1, 2 Dopamine D 3 receptor-selective partial agonist BP 897 inhibits drug-seeking behavior, which is induced by a brief stimulus previously paired with cocaine self-administration. 3 The effect of BP 897 is neither related to motor effects nor to reinforcing properties of this compound, which is not self-administered by rats 3 or monkeys. 4 Such procedures, widely used with psychostimulants, have not been developed with nicotine so far. Therefore, we have presently developed a simple procedure, based on Pavlovian conditioning, 5 to assess the effects of D 3 receptor ligands on nicotine cue-conditioned responses. Rats were injected with nicotine (0.5 mg/kg s.c.) and immediately placed in individual testing cages of an actimeter, which the animals presumably perceived as an environment distinct from their home environment. The procedure was repeated once a day for 5 days and locomotor responses were recorded during each session.
Upon repeated nicotine administrations in the particular environment, a progressive behavioral sensitization developed, which is reflected by a dayby-day enhancement of the locomotor response to the drug ( Figure 1 ). This strong behavioral sensitization may be partly determined by the association of the drug with a particular context, that is, contextdependent behavioral sensitization, already described 6 and suggested to take part in the development of compulsive drug-seeking behaviors. 7 Rats subjected to this conditioning procedure and subsequently exposed to the nicotine-paired environment displayed horizontal locomotor hyperactivity, even when they did not receive nicotine before re-exposure. Locomotor hyperactivity reflects conditioning elicited by the nicotine-paired environment, since it did not result from nicotine or the environment per se, but from the association of a particular environment with drug effects (Figure 2a) .
Development of context-dependent behavioral sensitization to nicotine, a dopamine-releasing drug, and subsequent reactivity to contextual nicotine-associated cues may involve similar adaptive changes in dopamine transmission, as previously described in the case of psychostimulants. 8, 9 Since increased dopamine release upon repeated nicotine administration has not been consistently observed, 10, 11 hyperresponsiveness to nicotine and nicotine-associated cues might be related to hypersensitive post-synaptic dopamine receptors. Among them, the D 3 receptor appears as a critical dopamine target, because its expression is concentrated in the shell of the nucleus accumbens (Figure 2b ), in which dopamine release is preferentially triggered by nicotine. 12 Moreover, D 3 receptor expression is highly dependent on dopamine neuron activity, 13 which is increased by nicotine. 12, 14 Using receptor autoradiography with a D 3 receptorselective radioligand, 15 we found a significant increase in D 3 receptor binding in the shell of the nucleus accumbens of rats treated with nicotine in the paired environment (Figure 2b and c) vs salinetreated rats. There was also a trend, although nonsignificant (P ¼ 0.07), for a higher D 3 receptor binding in rats receiving nicotine in the paired environment, as compared to the unpaired environment. The nicotine injection procedure in the unpaired environment could have produced some kind of conditioning, which could not be assessed behaviorally, and which could account for the small and nonsignificant increase in D 3 receptor binding in animals receiving nicotine, as compared to saline. An increase in D 3 receptor expression by nicotine conditioning was substantiated by the observation that D 3 receptor mRNA level in the shell of the nucleus accumbens was also upregulated (significant effect of nicotine: F[1,28] ¼ 6.24, P ¼ 0.02). We found a significant increase in D 3 receptor mRNA levels (+36%, P ¼ 0.005) in rats receiving nicotine in the paired environment, and also a small and nonsignificant increase (+16%, P ¼ 0.19) in rats receiving nicotine in the unpaired environment, as compared to salinetreated rats. In contrast, nicotine treatment had no significant effects on D 1 These results indicate a selective D 3 receptor overexpression produced by the association between the drug and the environment. The repetition of drug treatments also seems crucial, since no changes in D 3 receptor binding were noticed after a single nicotine administration (À11%, P ¼ 0.18). Interestingly, abnormal elevation of the D 3 receptor has also been documented in brain limbic regions of cocaine addicts. 16 Induction of D 3 receptor expression by drugs may represent a neuroadaptive process, leading to sustained enhancement of dopaminergic transmission in restricted areas where the D 3 receptor is expressed. In fact, in another animal model, behavioral sensitization has been causally related to D 3 receptor overexpression and hyperfunction. 17 Hence, We tested this idea by administering BP 897, a D 3 receptor-selective partial agonist, as previously assessed using rats and D 3 receptor gene targeted mice. 1 On the test day, the animals received BP 897 (1 mg/ kg), but not nicotine, 30 min before being placed in the conditioned environment. BP 897 inhibited locomotor hyperactivity elicited by the environment paired with nicotine, but not saline (Figure 3a) . Hyperactivity was apparent during the whole 30 min testing period of presentation of the nicotine-paired environment and BP 897 was active during this period of time (Figure 3b ). BP 897 was inactive on locomotor activity of saline-pretreated rats, suggesting the absence of effect on motor performance. Nevertheless, a disruptive effect of BP 897 on control locomotion could have been masked because the baseline rate of locomotion is low. However, placement of naive rats in the actimeter produced a novelty-induced locomotion, which was quantitatively comparable to the nicotine-conditioned locomotor activity (7375 counts for horizontal locomotor activity recorded during 30 min, n ¼ 6) and unaffected by BP 897 at 1 mg/kg (P ¼ 0.23, n ¼ 6, data not shown). These data confirm the absence of effects of BP 897 on motor performance, already shown by the ineffectiveness of this compound to disrupt cocainereinforced responses 1 and seeking responses for a natural reinforcer. 18 BP 897 at 0.1 or 0.3 mg/kg was ineffective to inhibit nicotine-conditioned locomotor activity (P ¼ 0.24 and 0.74, respectively, data not shown), in agreement with the dose-dependent effects of this compound for inhibiting cocaineseeking behavior. 1 In another experiment, we evaluated SB-277011-A, a D 3 receptor-selective antagonist devoid of any intrinsic activity in vitro at recombinant receptors. 19 The effect of SB-277011-A at doses of 3 and 10 mg/kg was similar to that produced by BP 897 at 1 mg/kg (Figure 3c ). The effect of SB-277011-A is unlikely to be related to a motor effect, since this compound does not interfere with basal locomotion. 19 The similar effects of BP 897 and SB-277011-A, two structurally unrelated chemicals, on nicotine-conditioned activity strongly suggest the participation of the D 3 receptor and that BP 897 acts as an antagonist in inhibiting nicotine-conditioned behavior, which is consistent with this compound producing both agonistic and antagonistic responses in vivo.
1 Interestingly, SB-277011-A was recently shown to inhibit cocaine cue-controlled drug-seeking behavior, but not only during the first drug-free interval of testing like BP 897, but also during the subsequent interval following cocaine infusion. 20 The differential effects of the two D 3 receptor ligands could be related to their different pharmacological profile as partial agonist vs pure antagonist in vitro. Importantly, inhibition of horizontal locomotor hyperactivity by the two D 3 rats receiving saline and SB-277011-A (10 mg/kg), respectively (P ¼ 0.88). In addition, continuous visual examination of the animals during exposure to the conditioned environment did not reveal any obvious appearance of other stereotypes, such as licking or grooming. This indicates that the treatments have, indeed, ablated the effects of nicotine cues rather than altered the pattern of the response.
Our results indicate that D 3 receptor overexpression and activation are involved not only in cocaine, 1 but also in nicotine cue-conditioned responses. They also indicate that blockade of the dopaminergic inputs reaching the restricted brain areas expressing the D 3 receptor is sufficient to impair the cue-induced behaviors. This is consistent with the dopamine neuron activation produced by reward-predicting stimuli and reward-resembling events, 21 like those elicited by a drug-paired environment, and suggests that similar disruption of conditioning could also be obtained in the case of other rewarding drugs, such as opiates or alcohol. These dopamine neurons project to g-aminobutyric acid neurons in the nucleus accumbens, a minority of which co-express D 1 and D 3 receptors. 22 Interestingly, inhibition of nicotine cue-conditioned effects is also produced by a D 1 receptor antagonist or vigabatrin, an indirect GABA agonist. 23 However, the latter agents elicit various side effects, limiting their clinical use. 24, 25 The effects of drug-associated cues are crucial for relapse in humans and probably reflect the progressive acquisition by these cues of an affective valence, often thought to be associated with incentive motivational properties. 26 Our study therefore suggests that D 3 receptor ligands, previously proposed in the treatment of cocaine addiction, 1,27 could be novel therapeutic tools to help smoking cessation by disrupting conditioning to environmental stimuli.
Methods

Animals and drug treatments
Subjects were male Sprague-Dawley rats (Iffa Credo, France), weighing 180-200 g at the beginning of the experiments. Animals were housed in groups of four per cage for 1 week prior to the experiments. Homecages measured 35 cm width Â 25 cm length Â 15 cm height. The light cycle was 07.00 lights on and 20.00 lights off. Food and water were provided ad libitum. All the animal procedures met the guidelines of the European Communities directive 86/609/EEC. Nicotine bitartrate (0.5 mg/kg) was dissolved in isotonic saline (0.9% sodium chloride) and neutralized to pH 7.4 with sodium hydroxide. Nicotine or saline was injected s.c. in a volume of 0.1 ml/100 g. BP 897 (Bioprojet, Paris, France) was dissolved in water, diluted in 0.9% saline, and injected i.p. SB-277011-A (kindly donated by GlaxoSmithKline, UK) was administered orally with methylcellulose 1%. All doses are expressed as the weight of the base. BP 897 and SB-277011-A were administered before the test phase, 30 min and 4 h before placement in the locomotor activity cages, respectively.
Behavioral procedures
All experiments were conducted between 13.00 and 18.00. Locomotor activity responses induced by acute administration of nicotine or saline were evaluated using locomotor activity cages (30 cm Â 15 cm Â 18 cm; Imetronic, Pessac, France). The boxes were equipped with one line of photocells placed 2 cm above the floor to measure horizontal movements and another line 8 cm above the floor to measure vertical activity (rearing). Counts for forward horizontal locomotion were incremented each time the animal moved from one half part of the cage to the other. We used the locomotor activity cages as conditioning compartments. The conditioning phase consisted of five pairings for a 30 min conditioning time. Rats (n ¼ 12 per group) were injected with either saline or nicotine (0.5 mg/kg s.c.) and then immediately individually confined to the conditioning compartment (paired environment). Control, unconditioned animals received saline or nicotine (n ¼ 8 per group), in their home-cages, 3 h before receiving saline and being placed into the locomotor activity cages (unpaired environment) for 30 min. The procedure was performed once a day for 5 days. At the end of the conditioning procedure, the animals were kept in their home-cages in their original groups without drug or manipulation for 72 h. The test phase was conducted as the conditioning phase, except that all rats received saline administration before placement in the locomotor activity cages (representing a paired or unpaired environment depending on the conditioning phase). Thus, during the test phase, the locomotor activity was induced by saline or nicotine-associated cues only. Two hours after the test phase, saline-or nicotine-treated rats in the paired (n ¼ 8, randomly chosen out of 12) or unpaired environment (n ¼ 8) were killed by cervical dislocation, and decapitated. Their brains were rapidly removed, frozen in isopentane at À301C, and stored at À801C until use. A similar experiment was performed with rats receiving saline (n ¼ 24) or nicotine (n ¼ 40) during the conditioning phase, then half of the rats received either saline or BP 897 (1 mg/ kg i.p.) before the test phase. Finally, an experiment was performed in rats receiving nicotine (n ¼ 8 per group) during the conditioned phase and saline, BP 897 (0.1 or 0.3 mg/kg i.p.) or SB-277011-A (3 or 10 mg/ kg p.o.) on the test session in the nicotine-paired environment. Naive rats (n ¼ 6) pretreated either with saline or with BP 897 (1 mg/kg i.p.) were placed in locomotor activity cages for measurement of noveltyinduced locomotion. ([  125 I ]trans-7-OH-PIPAT, 2200 Ci/mmol, Amersham). Unfixed brain sections were preincubated at room temperature three times for 5 min in 50 mM sodium-HEPES buffer (pH 7.5) containing 1 mM EDTA and 0.1% BSA. They were then incubated for 45 min at room temperature in the same buffer containing [ 125 I]trans-7-OH-PIPAT. Nonspecific binding was determined by incubating adjacent sections in the same medium in the presence of 1 mM dopamine. After incubation, slices were washed four times for 2 min in ice-cold sodium-HEPES buffer containing 100 mM NaCl, dipped in ice-cold distilled water, and then dried under a stream of cold air. Autoradiograms were generated by apposing sections to In situ hybridization Paraformaldehyde-fixed sections (10 mm) were treated with proteinase K (1 mg/ml) and then with 0.25% acetic anhydride in triethanolamine buffer. The sections were hybridized with 33 P-radiolabeled cRNA respective probes for D 1 , D 2 and D 3 receptor mRNAs (2 Â 10 6 dpm per slide) in 65% deionized formamide, 10% dextran sulfate, 1 Â Denhardt's solution, 2 Â SSC, 0.1% sodium pyrophosphate, 100 mg/ml yeast tRNA, and 100 mg/ml denatured salmon sperm DNA. After incubation and rinsing, sections were 
Receptor autoradiography
Data analyses
Autoradiographic signals in the nucleus accumbens were quantified on 2-3 sections per animal using an image analyser (IMSTAR, Paris, France). Gray values were converted to mCi per gram wet weight using standard stripes (Amersham, Buckinghamshire, UK). Between-group differences were analysed with the Statistica TM software using two-way analysis of variance (ANOVA) and least significance difference (LSD) post hoc tests. For the analysis of data obtained from repeated nicotine administration and the timecourse of conditioned locomotor activity, in which the same animals were evaluated on several occasions, a between-within univariate ANOVA for repeated measures was used.
